TerminatedNCT02259517
An fMRI Study of Stimulant vs. Non-Stimulant Treatment of ADHD
Medication studyAges 6–17United States
Understand this study
Who could participate?
Listed age limits: 6 years to 17 years.
- Listed locations
- New YorkSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: September 2014
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 38
- Sponsor
- New York State Psychiatric Institute
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 6 Years to 17 Years
- Official registry ID
- NCT02259517
- Official title
Show the full official title
Imaging Stimulant vs. Non-Stimulant Treatment of Attention Deficit Hyperactivity Disorder (ADHD)
Recruitment & locations
TerminatedNew York
A listed location does not confirm current availability.
Questions about this study
What will I need to do?
You will take study medication.
Who is behind this study?
The study sponsor is New York State Psychiatric Institute, a research institute.
Does this study involve medication?
Yes. The study involves medication, including Guanfacine and Lisdexamfetamine.
Who can participate?
Listed age limits: 6 years to 17 years.
Is this study still recruiting?
The registry lists this study as terminated.
Want to explore more studies?
Explore studiesRelated studies
A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder
A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR With NRCT-202XR Compared to NRCT-202XR Alone in Subjects With Attention-Deficit/Hyperactivity Disorder